NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00025415 2013-02-07Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionNational Cancer Institute (NCI)Phase 1 Completed60 enrolled